SCHEMBL16639754

SCHEMBL16639754

Cc1c(C(=O)NCc2ccc(S(=O)(=O)N3CCOCC3)cc2)oc2ccc(Cl)cc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.80
HTT P42858 5/20 0.80
NPSR1 Q6W5P4 3/20 0.80
USP2 O75604 7/20 0.66
TDP1 Q9NUW8 2/20 0.66
ALDH1A1 P00352 7/20 0.66
MAPT P10636 1/20 0.64
TP53 P04637 1/20 0.64
TSHR P16473 2/20 0.64
GAA P10253 1/20 0.61
MAPK1 P28482 3/20 0.61
HSD17B10 Q99714 2/20 0.61
KMT2A Q03164 2/20 0.60
KDM4E B2RXH2 2/20 0.60
PKM P14618 1/20 0.60
HPGD P15428 1/20 0.60
MEN1 O00255 1/20 0.60
LMNA P02545 2/20 0.60
ALOX15 P16050 1/20 0.60
CNR1 P21554 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16639753 0.92 SMN1; SMN2 (0.75) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL16639798 0.88 SMN1; SMN2 (0.78) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL10260221 0.87 SMN1; SMN2 (0.86) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL10261335 0.81 SMN1; SMN2 (0.86) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL16639779 0.79 SMN1; SMN2 (0.65) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL8275548 0.79 ALDH1A1 (0.98) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL10259647 0.79 ALDH1A1 (0.98) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL8276725 0.78 ALDH1A1 (0.73) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL10259973 0.77 TDP1 (1.00) SMN1; SMN2HTTNPSR1USP2TDP1
SCHEMBL16644218 0.77 MAPT (0.57) SMN1; SMN2MAPTMAPK1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696692-B2 Amido-benzyl sulfone and sulfoxide derivates Valo Health, LLC 2020-06-30 US disclosed
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10696692-B2 Amido-benzyl sulfone and sulfoxide derivates STS, SQOR, SULT1E1 SMN1; SMN2 346/4885HTT 298/4885NPSR1 635/4885
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES STS, SULT1E1, CBS SMN1; SMN2 616/4885HTT 788/4885NPSR1 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.